Brief: Bausch Health Provides Update On RED-C Phase 3 Clinical Trials
23/01/2026 12:48
Jan 23 (Reuters) - Bausch Health Companies Inc BHC.TO: BAUSCH HEALTH PROVIDES UPDATE ON RED-C PHASE 3 CLINICAL TRIALS BAUSCH HEALTH COMPANIES INC - PHASE 3 TRIALS DID NOT MEET PRIMARY ENDPOINT Source text: ID:nCNWFGCR8a Further company coverage: BHC.TO ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bausch Health Companies
See all newsCanada Stocks: TSX heads for monthly gain as mining stocks rise, oil retreats
Canada's Bausch Health Q1 revenue rises
Canada's Bausch Health beats Q1 adjusted EPS estimates
Pfizer, Teva lose bid to disqualify ex-prosecutor in generic drug price‑fixing case
Canada Stocks: TSX subdued as healthcare, financials drag; energy gains